Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$347M |
| 2 |
FedEx
FDX
|
+$242M |
| 3 |
Y
Alleghany Corp
Y
|
+$46.4M |
| 4 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
+$34.7M |
| 5 |
Wells Fargo
WFC
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$550M |
| 2 |
Amazon
AMZN
|
+$169M |
| 3 |
JPMorgan Chase
JPM
|
+$152M |
| 4 |
Visa
V
|
+$95.4M |
| 5 |
UnitedHealth
UNH
|
+$66.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.79% |
| 2 | Consumer Discretionary | 13.4% |
| 3 | Communication Services | 12.27% |
| 4 | Energy | 10.41% |
| 5 | Industrials | 9.08% |
Similar funds
Christopher Davis's Q2 2017 Portfolio in Review
As of Q2 2017, Christopher Davis held 146 positions worth $22.9B, down 1.4% from $23.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Christopher Davis withdrew a net $1.06B in Q2 2017, closing 4 positions and reducing 74 holdings. Its most notable exit was Bausch Health, an estimated $43.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Christopher Davis opened a new position in Alleghany Corp worth $46.4M.
- Christopher Davis's largest Q2 2017 buy was Alleghany Corp: 77,974 shares worth $46.4M.
- Christopher Davis added most to Capital One in Q2 2017, an estimated $347M increase.
- Christopher Davis's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $550M.
- Christopher Davis fully exited Bausch Health in Q2 2017, selling an estimated $43.2M.
- Christopher Davis's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2017.
- Christopher Davis opened 5 new positions and closed 4 in Q2 2017.
- Christopher Davis's portfolio value fell 1.4% quarter-over-quarter to $22.9B.
Based on Davis Selected Advisers's 13F filing for Q2 2017, filed 9 Aug 2017.